Flavonoids and the gastrointestinal tract: Local and systemic effects

Molecular Aspects of Medicine

Volumn 61, Issue , 2018, Pages 41-49

  Oteiza, P I ^a   Fraga, C G ^a,b   Mills, D A ^a   Taft, D H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Endotoxemia; Flavonoid; Gastrointestinal tract; Incretins; Intestinal permeability; Microbiota

Indexed keywords

FLAVONOID;

COLORECTAL CANCER; ENDOCRINE SYSTEM; GASTROINTESTINAL DISEASE; GASTROINTESTINAL TRACT; HUMAN; IMMUNE SYSTEM; INFLAMMATORY DISEASE; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; METABOLIC DISORDER; METABOLISM; NONHUMAN; REVIEW; HEALTH; MICROBIOLOGY; PATHOLOGY;

FLAVONOIDS; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HEALTH; HUMANS;

EID: 85040443288     PISSN: 00982997     EISSN: 18729452     Source Type: Journal    
DOI: 10.1016/j.mam.2018.01.001     Document Type: Review

References (112)

1. Actis-Goretta, L., Leveques, A., Rein, M., Teml, A., Schafer, C., Hofmann, U., Li, H., Schwab, M., Eichelbaum, M., Williamson, G., Intestinal absorption, metabolism, and excretion of (-)-epicatechin in healthy humans assessed by using an intestinal perfusion technique. Am. J. Clin. Nutr. 98 (2013), 924–933.
2. Amar, J., Burcelin, R., Ruidavets, J.B., Cani, P.D., Fauvel, J., Alessi, M.C., Chamontin, B., Ferrieres, J., Energy intake is associated with endotoxemia in apparently healthy men. Am. J. Clin. Nutr. 87 (2008), 1219–1223.
3. Appeldoorn, M.M., Vincken, J.P., Aura, A.M., Hollman, P.C., Gruppen, H., Procyanidin dimers are metabolized by human microbiota with 2-(3,4-dihydroxyphenyl)acetic acid and 5-(3,4-dihydroxyphenyl)-gamma-valerolactone as the major metabolites. J. Agric. Food Chem. 57 (2009), 1084–1092.
4. Araya-Cloutier, C., den Besten, H.M., Aisyah, S., Gruppen, H., Vincken, J.-P., The position of prenylation of isoflavonoids and stilbenoids from legumes (Fabaceae) modulates the antimicrobial activity against Gram positive pathogens. Food Chem. 226 (2017), 193–201.
5. Aune, D., Lau, R., Chan, D.S., Vieira, R., Greenwood, D.C., Kampman, E., Norat, T., Nonlinear reduction in risk for colorectal cancer by fruit and vegetable intake based on meta-analysis of prospective studies. Gastroenterology 141 (2011), 106–118.
6. Baldassano, S., Amato, A., Mule, F., Influence of glucagon-like peptide 2 on energy homeostasis. Peptides 86 (2016), 1–5.
7. Ben, Q., Sun, Y., Chai, R., Qian, A., Xu, B., Yuan, Y., Dietary fiber intake reduces risk for colorectal adenoma: a meta-analysis. Gastroenterology, 146, 2014, e686 689–699.
8. Bettaieb, A., Cremonini, E., Kang, H., Kang, J., Haj, F.G., Oteiza, P.I., Anti-inflammatory actions of (-)-epicatechin in the adipose tissue of obese mice. Int. J. Biochem. Cell Biol. 81:Pt B (2016), 383–392.
9. Bettaieb, A., Vazquez-Prieto, M.A., Lanzi, C.R., Miatello, R.M., Haj, F.G., Fraga, C.G., Oteiza, P.I., (-)-Epicatechin mitigates high fructose-associated insulin resistance by modulating redox signaling and endoplasmic reticulum stress. Free Radic. Biol. Med. 72 (2014), 247–256.
10. Biasi, F., Mascia, C., Poli, G., The contribution of animal fat oxidation products to colon carcinogenesis, through modulation of TGF-beta1 signaling. Carcinogenesis 29:5 (2008), 890–894.
11. Bindels, L.B., Delzenne, N.M., Cani, P.D., Walter, J., Towards a more comprehensive concept for prebiotics. Nat. Rev. Gastroenterol. Hepatol. 12 (2015), 303–310.
12. Borges, G., Ottaviani, J.I., van der Hooft, J.J.J., Schroeter, H., Crozier, A., Absorption, metabolism, distribution and excretion of (-)-epicatechin: a review of recent findings. Mol. Aspect. Med., 2017 S0098-2997(17)30143-7 https://doi.org/10.1016/j.mam.2017.11.002 [Epub ahead of print].
13. Braune, A., Blaut, M., Bacterial species involved in the conversion of dietary flavonoids in the human gut. Gut Microb. 7:3 (2016), 216–234.
14. Brown, E.M., Sadarangani, M., Finlay, B.B., The role of the immune system in governing host-microbe interactions in the intestine. Nat. Immunol. 14 (2013), 660–667.
15. Campbell, J.E., Drucker, D.J., Pharmacology, physiology, and mechanisms of incretin hormone action. Cell Metab 17 (2013), 819–837.
16. Cani, P.D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A.M., Delzenne, N.M., Burcelin, R., Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57 (2008), 1470–1481.
17. Cani, P.D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., Geurts, L., Naslain, D., Neyrinck, A., Lambert, D.M., Muccioli, G.G., Delzenne, N.M., Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58 (2009), 1091–1103.
18. Carrasco-Pozo, C., Morales, P., Gotteland, M., Polyphenols protect the epithelial barrier function of Caco-2 cells exposed to indomethacin through the modulation of occludin and zonula occludens-1 expression. J. Agric. Food Chem. 61 (2013), 5291–5297.
19. Cassidy, A., Minihane, A.-M., The role of metabolism (and the microbiome) in defining the clinical efficacy of dietary flavonoids. Am. J. Clin. Nutr. 105 (2017), 10–22.
20. Choy, Y.Y., Fraga, M., Mackenzie, G.G., Waterhouse, A.L., Cremonini, E., Oteiza, P.I., The PI3K/Akt pathway is involved in procyanidin-mediated suppression of human colorectal cancer cell growth. Mol. Carcinog. 55 (2016), 2196–2209.
21. Choy, Y.Y., Jaggers, G.K., Oteiza, P.I., Waterhouse, A.L., Bioavailability of intact proanthocyanidins in the rat colon after ingestion of grape seed extract. J. Agric. Food Chem. 61 (2013), 121–127.
22. Choy, Y.Y., Quifer-Rada, P., Holstege, D.M., Frese, S.A., Calvert, C.C., Mills, D.A., Lamuela-Raventos, R.M., Waterhouse, A.L., Phenolic metabolites and substantial microbiome changes in pig feces by ingesting grape seed proanthocyanidins. Food Funct. 5 (2014), 2298–2308.
23. Contreras, T.C., Ricciardi, E., Cremonini, E., Oteiza, P.I., (-)-Epicatechin in the prevention of tumor necrosis alpha-induced loss of Caco-2 cell barrier integrity. Arch. Biochem. Biophys. 573 (2015), 84–91.
24. Cremonini, E., Bettaieb, A., Haj, F.G., Fraga, C.G., Oteiza, P.I., (-)-Epicatechin improves insulin sensitivity in high fat diet-fed mice. Arch. Biochem. Biophys. 599 (2016), 13–21.
25. Cremonini, E., Mastaloudis, A., Hester, S.N., Verstraeten, S.V., Anderson, M., Wood, S.M., Waterhouse, A.L., Fraga, C.G., Oteiza, P.I., Anthocyanins inhibit tumor necrosis alpha-induced loss of Caco-2 cell barrier integrity. Food Funct. 8 (2017), 2915–2923.
26. Cremonini, E., Wang, Z., Bettaieb, A., Adamo, A.M., daveri, E., Mills, D.A., Kalanetra, K., Haj, F.G., Karakas, S., Oteiza, P.I., (-)-Epicatechin protects the intestinal barrier from high fat diet-induced permeabilization: implications for steatosis and insulin resistance. Redox Biol. 14 (2018), 588–599 https://doi.org/10.1016/j.redox.2017.11.002.
27. Crozier, A., Del Rio, D., Clifford, M.N., Bioavailability of dietary flavonoids and phenolic compounds. Mol. Aspects Med. 3 (2010), 446–467.
28. Cuervo, A., Hevia, A., López, P., Suárez, A., Sánchez, B., Margolles, A., González, S., Association of polyphenols from oranges and apples with specific intestinal microorganisms in systemic Lupus Erythematosus patients. Nutrients 7 (2015), 1301–1317.
29. Cushnie, T.T., Lamb, A.J., Antimicrobial activity of flavonoids. Int. J. Antimicrob. Agents 26 (2005), 343–356.
30. Da Silva, M., Jaggers, G.K., Verstraeten, S.V., Erlejman, A.G., Fraga, C.G., Oteiza, P.I., Large procyanidins prevent bile-acid-induced oxidant production and membrane-initiated ERK1/2, p38, and Akt activation in Caco-2 cells. Free Radic. Biol. Med. 52 (2012), 151–159.
31. David, L.A., Maurice, C.F., Carmody, R.N., Gootenberg, D.B., Button, J.E., Wolfe, B.E., Ling, A.V., Devlin, A.S., Varma, Y., Fischbach, M.A., Biddinger, S.B., Dutton, R.J., Turnbaugh, P.J., Diet rapidly and reproducibly alters the human gut microbiome. Nature 505 (2014), 559–563.
32. Davison, K., Coates, A.M., Buckley, J.D., Howe, P.R., Effect of cocoa flavanols and exercise on cardiometabolic risk factors in overweight and obese subjects. Int. J. Obes. (Lond) 32 (2008), 1289–1296.
33. de Araújo, M.E.M.B., Franco, Y.E.M., Alberto, T.G., Sobreiro, M.A., Conrado, M.A., Priolli, D.G., Sawaya, A.C.F., Ruiz, A.L.T., de Carvalho, J.E., de Oliveira Carvalho, P., Enzymatic de-glycosylation of rutin improves its antioxidant and antiproliferative activities. Food Chem. 141 (2013), 266–273.
34. De Leoz, M.L.A., Kalanetra, K.M., Bokulich, N.A., Strum, J.S., Underwood, M.A., German, J.B., Mills, D.A., Lebrilla, C.B., Human milk glycomics and gut microbial genomics in infant feces show a correlation between human milk oligosaccharides and gut microbiota: a proof-of-concept study. J. Proteome Res. 14 (2015), 491–502.
35. Deacon, C.F., Nauck, M.A., Toft-Nielsen, M., Pridal, L., Willms, B., Holst, J.J., Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects. Diabetes 44 (1995), 1126–1131.
36. Dower, J.I., Geleijnse, J.M., Gijsbers, L., Zock, P.L., Kromhout, D., Hollman, P.C., Effects of the pure flavonoids epicatechin and quercetin on vascular function and cardiometabolic health: a randomized, double-blind, placebo-controlled, crossover trial. Am. J. Clin. Nutr. 101 (2015), 914–921.
37. Drucker, D.J., Yusta, B., Physiology and pharmacology of the enteroendocrine hormone glucagon-like peptide-2. Annu. Rev. Physiol. 76 (2014), 561–583.
38. Duda-Chodak, A., The inhibitory effect of polyphenols on human gut microbiota. J. Physiol. Pharmacol. 63 (2012), 497–503.
39. Erlejman, A.G., Fraga, C.G., Oteiza, P.I., Procyanidins protect Caco-2 cells from bile acid- and oxidant-induced damage. Free Radic. Biol. Med. 41 (2006), 1247–1256.
40. Erlejman, A.G., Verstraeten, S.V., Fraga, C.G., Oteiza, P.I., The interaction of flavonoids with membranes: potential determinant of flavonoid antioxidant effects. Free Radic. Res. 38 (2004), 1311–1320.
41. Espley, R.V., Butts, C.A., Laing, W.A., Martell, S., Smith, H., McGhie, T.K., Zhang, J., Paturi, G., Hedderley, D., Bovy, A., Schouten, H.J., Putterill, J., Allan, A.C., Hellens, R.P., Dietary flavonoids from modified apple reduce inflammation markers and modulate gut microbiota in mice. J. Nutr. 144 (2014), 146–154.
42. Fasano, A., Shea-Donohue, T., Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases. Nat. Clin. Pract. Gastroenterol. Hepatol. 2 (2005), 416–422.
43. Fei, Q., Gao, Y., Zhang, X., Sun, Y., Hu, B., Zhou, L., Jabbar, S., Zeng, X., Effects of Oolong tea polyphenols, EGCG, and EGCG3’Me on pancreatic alpha-amylase activity in vitro. J. Agric. Food Chem. 62 (2014), 9507–9514.
44. Forester, S.C., Waterhouse, A.L., Gut metabolites of anthocyanins, gallic acid, 3-O-methylgallic acid, and 2,4,6-trihydroxybenzaldehyde, inhibit cell proliferation of Caco-2 cells. J. Agric. Food Chem. 58, 5320–5327.
45. Fraga, C.G., Plant polyphenols: how to translate their in vitro antioxidant actions to in vivo conditions. IUBMB Life 59 (2007), 308–315.
46. Galleano, M., Verstraeten, S.V., Oteiza, P.I., Fraga, C.G., Antioxidant actions of flavonoids: thermodynamic and kinetic analysis. Arch. Biochem. Biophys. 501 (2010), 23–30.
47. Gibson, G.R., Hutkins, R., Sanders, M.E., Prescott, S.L., Reimer, R.A., Salminen, S.J., Scott, K., Stanton, C., Swanson, K.S., Cani, P.D., Verbeke, K., Reid, G., Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat. Rev. Gastroenterol. Hepatol. 14:8 (2017), 491–502.
48. Gil-Cardoso, K., Gines, I., Pinent, M., Ardevol, A., Arola, L., Blay, M., Terra, X., Chronic supplementation with dietary proanthocyanidins protects from diet-induced intestinal alterations in obese rats. Mol. Nutr. Food Res., 2017, 10.1002/mnfr.201601039.
49. Gonzales, G.B., Smagghe, G., Grootaert, C., Zotti, M., Raes, K., Van Camp, J., Flavonoid interactions during digestion, absorption, distribution and metabolism: a sequential structure-activity/property relationship-based approach in the study of bioavailability and bioactivity. Drug Metab. Rev. 47 (2015), 175–190.
50. Gonzalez-Abuin, N., Martinez-Micaelo, N., Margalef, M., Blay, M., Arola-Arnal, A., Muguerza, B., Ardevol, A., Pinent, M., A grape seed extract increases active glucagon-like peptide-1 levels after an oral glucose load in rats. Food Funct. 5 (2014), 2357–2364.
51. Gosse, F., Guyot, S., Roussi, S., Lobstein, A., Fischer, B., Seiler, N., Raul, F., Chemopreventive properties of apple procyanidins on human colon cancer-derived metastatic SW620 cells and in a rat model of colon carcinogenesis. Carcinogenesis 26 (2005), 1291–1295.
52. Grassi, D., Desideri, G., Necozione, S., Lippi, C., Casale, R., Properzi, G., Blumberg, J.B., Ferri, C., Blood pressure is reduced and insulin sensitivity increased in glucose-intolerant, hypertensive subjects after 15 days of consuming high-polyphenol dark chocolate. J. Nutr. 138 (2008), 1671–1676.
53. Grassi, D., Lippi, C., Necozione, S., Desideri, G., Ferri, C., Short-term administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons. Am. J. Clin. Nutr. 81 (2005), 611–614.
54. Gribble, F.M., Reimann, F., Enteroendocrine Cells: Chemosensors in the Intestinal Epithelium. Annu. Rev. Physiol 78 (2016), 277–299.
55. Grosso, G., Godos, J., Lamuela-Raventos, R., Ray, S., Micek, A., Pajak, A., Sciacca, S., D'Orazio, N., Del Rio, D., Galvano, F., A comprehensive meta-analysis on dietary flavonoid and lignan intake and cancer risk: level of evidence and limitations. Mol. Nutr. Food Res., 2017, 10.1002/mnfr.201600930.
56. Gueraud, F., Tache, S., Steghens, J.P., Milkovic, L., Borovic-Sunjic, S., Zarkovic, N., Gaultier, E., Naud, N., Helies-Toussaint, C., Pierre, F., Priymenko, N., Dietary polyunsaturated fatty acids and heme iron induce oxidative stress biomarkers and a cancer promoting environment in the colon of rats. Free Radic. Biol. Med. 83 (2015), 192–200.
57. Gutierrez-Salmean, G., Ortiz-Vilchis, P., Vacaseydel, C.M., Garduno-Siciliano, L., Chamorro-Cevallos, G., Meaney, E., Villafana, S., Villarreal, F., Ceballos, G., Ramirez-Sanchez, I., Effects of (-)-epicatechin on a diet-induced rat model of cardiometabolic risk factors. Eur. J. Pharmacol. 728 (2014), 24–30.
58. Gwiazdowska, D., Juś K., Jasnowska-Małecka, J., Kluczyńska, K., The impact of polyphenols on Bifidobacterium growth. Acta Biochim. Pol. 62:4 (2015), 895–901.
59. Harte, A.L., Varma, M.C., Tripathi, G., McGee, K.C., Al-Daghri, N.M., Al-Attas, O.S., Sabico, S., O'Hare, J.P., Ceriello, A., Saravanan, P., Kumar, S., McTernan, P.G., High fat intake leads to acute postprandial exposure to circulating endotoxin in type 2 diabetic subjects. Diabetes Care 35 (2012), 375–382.
60. He, X., Sun, L.M., Dietary intake of flavonoid subclasses and risk of colorectal cancer: evidence from population studies. Oncotarget 7 (2016), 26617–26627.
61. Hollman, P.C.H., Absorption, bioavailability, and metabolism of flavonoids. Pharm. Biol. 42:Suppl. 1 (2004), 74–83.
62. Hutkins, R.W., Krumbeck, J.A., Bindels, L.B., Cani, P.D., Fahey, G. Jr., Goh, Y.J., Hamaker, B., Martens, E.C., Mills, D.A., Rastal, R.A., Vaughan, E., Sanders, M.E., Prebiotics: why definitions matter. Curr. Opin. Biotechnol. 37 (2016), 1–7.
63. Kato, M., Tani, T., Terahara, N., Tsuda, T., The anthocyanin delphinidin 3-rutinoside stimulates glucagon-like Peptide-1 secretion in murine GLUTag cell line via the Ca2+/Calmodulin-Dependent kinase II pathway. PLoS One, 10(5), 2015, e0126157.
64. Kay, C.D., Pereira-Caro, G., Ludwig, I.A., Clifford, M.N., Crozier, A., Anthocyanins and flavanones are more bioavailable than previously perceived: a review of recent evidence. Annu. Rev. Food Sci. Technol. 8 (2017), 155–180.
65. Kim, D.H., Jung, E.A., Sohng, I.S., Han, J.A., Kim, T.H., Han, M.J., Intestinal bacterial metabolism of flavonoids and its relation to some biological activities. Arch. Pharm. Res. 21 (1998), 17–23.
66. Kumar, S., Pandey, A.K., Chemistry and biological activities of flavonoids: an overview. Sci. World J., 2013, 2013 162750.
67. Laugerette, F., Alligier, M., Bastard, J.P., Drai, J., Chanseaume, E., Lambert-Porcheron, S., Laville, M., Morio, B., Vidal, H., Michalski, M.C., Overfeeding increases postprandial endotoxemia in men: inflammatory outcome may depend on LPS transporters LBP and sCD14. Mol. Nutr. Food Res. 58 (2014), 1513–1518.
68. Long, S.L., Gahan, C.G.M., Joyce, S.A., Interactions between gut bacteria and bile in health and disease. Mol. Aspects Med. 56 (2017), 54–65.
69. Mascia, C., Maina, M., Chiarpotto, E., Leonarduzzi, G., Poli, G., Biasi, F., Proinflammatory effect of cholesterol and its oxidation products on CaCo-2 human enterocyte-like cells: effective protection by epigallocatechin-3-gallate. Free Radic. Biol. Med. 49 (2010), 2049–2057.
70. Martinot, E., Sèdes, L., Baptissart, M., Lobaccaro, J.M., Caira, F., Beaudoin, C., Volle, D.H., Bile acids and their receptors. Mol. Aspects Med. 56 (2017), 2–9.
71. Masumoto, S., Terao, A., Yamamoto, Y., Mukai, T., Miura, T., Shoji, T., Non-absorbable apple procyanidins prevent obesity associated with gut microbial and metabolomic changes. Sci. Rep., 6, 2016, 31208.
72. Maynard, C.L., Elson, C.O., Hatton, R.D., Weaver, C.T., Reciprocal interactions of the intestinal microbiota and immune system. Nature 489:7415 (2012), 231–241.
73. Nakai, M., Fukui, Y., Asami, S., Toyoda-Ono, Y., Iwashita, T., Shibata, H., Mitsunaga, T., Hashimoto, F., Kiso, Y., Inhibitory effects of oolong tea polyphenols on pancreatic lipase in vitro. J. Agric. Food Chem. 53 (2005), 4593–4598.
74. Nimptsch, K., Zhang, X., Cassidy, A., Song, M., O'Reilly, E.J., Lin, J.H., Pischon, T., Rimm, E.B., Willett, W.C., Fuchs, C.S., Ogino, S., Chan, A.T., Giovannucci, E.L., Wu, K., Habitual intake of flavonoid subclasses and risk of colorectal cancer in 2 large prospective cohorts. Am. J. Clin. Nutr. 103 (2016), 184–191.
75. Nohynek, L.J., Alakomi, H.-L., Kähkönen, M.P., Heinonen, M., Helander, I.M., Oksman-Caldentey, K.-M., Puupponen-Pimiä R.H., Berry phenolics: antimicrobial properties and mechanisms of action against severe human pathogens. Nutr. Cancer 54 (2006), 18–32.
76. Odenwald, M.A., Turner, J.R., The intestinal epithelial barrier: a therapeutic target?. Nat. Rev. Gastroenterol. Hepatol. 14 (2017), 9–21.
77. Olejnik, A., Kowalska, K., Kidon, M., Czapski, J., Rychlik, J., Olkowicz, M., Dembczynski, R., Purple carrot anthocyanins suppress lipopolysaccharide-induced inflammation in the co-culture of intestinal Caco-2 and macrophage RAW264.7 cells. Food Funct. 7 (2016), 557–564.
78. Pierre, J.F., Heneghan, A.F., Feliciano, R.P., Shanmuganayagam, D., Krueger, C.G., Reed, J.D., Kudsk, K.A., Cranberry proanthocyanidins improve intestinal sIgA during elemental enteral nutrition. JPEN J. Parenter. Enteral. Nutr. 38 (2014), 107–114.
79. Pierre, J.F., Heneghan, A.F., Feliciano, R.P., Shanmuganayagam, D., Roenneburg, D.A., Krueger, C.G., Reed, J.D., Kudsk, K.A., Cranberry proanthocyanidins improve the gut mucous layer morphology and function in mice receiving elemental enteral nutrition. JPEN J. Parenter. Enteral. Nutr 37 (2013), 401–409.
80. Pinent, M., Blay, M., Serrano, J., Ardevol, A., Effects of flavanols on the enteroendocrine system: repercussions on food intake. Crit. Rev. Food Sci. Nutr. 57 (2017), 326–334.
81. Porras, D., Nistal, E., Martínez-Flórez, S., Pisonero-Vaquero, S., Olcoz, J.L., Jover, R., González-Gallego, J., García-Mediavilla, M.V., Sánchez-Campos, S., Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation. Free Radic. Biol. Med. 102 (2017), 188–202.
82. Rajeev, S.P., Wilding, J., GLP-1 as a target for therapeutic intervention. Curr. Opin. Pharmacol. 31 (2016), 44–49.
83. Remely, M., Haslberger, A.G., The microbial epigenome in metabolic syndrome. Mol. Aspects Med. 54 (2017), 71–77.
84. Ridlon, J.M., Kang, D.J., Hylemon, P.B., Bajaj, J.S., Bile acids and the gut microbiome. Curr. Opin. Gastroenterol. 30 (2014), 332–338.
85. Rossi, M., Bosetti, C., Negri, E., Lagiou, P., La Vecchia, C., Flavonoids, proanthocyanidins, and cancer risk: a network of case-control studies from Italy. Nutr. Cancer 62 (2010), 871–877.
86. Rossi, M., Negri, E., Parpinel, M., Lagiou, P., Bosetti, C., Talamini, R., Montella, M., Giacosa, A., Franceschi, S., La Vecchia, C., Proanthocyanidins and the risk of colorectal cancer in Italy. Canc. Causes Contr. 21 (2010), 243–250.
87. Salaritabar, A., Darvishi, B., Hadjiakhoondi, F., Manayi, A., Sureda, A., Nabavi, S.F., Fitzpatrick, L.R., Nabavi, S.M., Bishayee, A., Therapeutic potential of flavonoids in inflammatory bowel disease: a comprehensive review. World J. Gastroenterol. 23 (2017), 5097–5114.
88. Shen, J., Obin, M.S., Zhao, L., The gut microbiota, obesity and insulin resistance. Mol. Aspects Med. 34:1 (2013), 39–58.
89. Shortt, C., Hasselwander, O., Meynier, A., Nauta, A., Fernández, E.N., Putz, P., Rowland, I., Swann, J., Türk, J., Vermeiren, J., Antoine, J.M., Systematic review of the effects of the intestinal microbiota on selected nutrients and non-nutrients. Eur. J. Nutr., 2017, 10.1007/s00394-017-1546-4.
90. Shrime, M.G., Bauer, S.R., McDonald, A.C., Chowdhury, N.H., Coltart, C.E., Ding, E.L., Flavonoid-rich cocoa consumption affects multiple cardiovascular risk factors in a meta-analysis of short-term studies. J. Nutr. 141 (2011), 1982–1988.
91. Singh, D.P., Borse, S.P., Nivsarkar, M., Overcoming the exacerbating effects of ranitidine on NSAID-induced small intestinal toxicity with quercetin: providing a complete GI solution. Chem. Biol. Interact. 272 (2017), 53–64.
92. Steed, A.L., Christophi, G.P., Kaiko, G.E., Sun, L., Goodwin, V.M., Jain, U., Esaulova, E., Artyomov, M.N., Morales, D.J., Holtzman, M.J., Boon, A.C.M., Lenschow, D.J., Stappenbeck, T.S., The microbial metabolite desaminotyrosine protects from influenza through type I interferon. Science 357:6350 (2017), 498–502.
93. Sugiyama, H., Akazome, Y., Shoji, T., Yamaguchi, A., Yasue, M., Kanda, T., Ohtake, Y., Oligomeric procyanidins in apple polyphenol are main active components for inhibition of pancreatic lipase and triglyceride absorption. J. Agric. Food Chem. 55 (2007), 4604–4609.
94. Suzuki, T., Hara, H., Quercetin enhances intestinal barrier function through the assembly of zonula [corrected] occludens-2, occludin, and claudin-1 and the expression of claudin-4 in Caco-2 cells. J. Nutr. 139 (2009), 965–974.
95. Suzuki, T., Hara, H., Dietary fat and bile juice, but not obesity, are responsible for the increase in small intestinal permeability induced through the suppression of tight junction protein expression in LETO and OLETF rats. Nutr. Metab. (Lond), 7, 2010, 19.
96. Tabasco, R., Sanchez-Patan, F., Monagas, M., Bartolome, B., Victoria Moreno-Arribas, M., Pelaez, C., Requena, T., Effect of grape polyphenols on lactic acid bacteria and bifidobacteria growth: resistance and metabolism. Food Microbiol. 28 (2011), 1345–1352.
97. Terry, P., Giovannucci, E., Michels, K.B., Bergkvist, L., Hansen, H., Holmberg, L., Wolk, A., Fruit, vegetables, dietary fiber, and risk of colorectal cancer. J. Natl. Cancer Inst. 93 (2001), 525–533.
98. Tsang, C., Auger, C., Mullen, W., Bornet, A., Rouanet, J.M., Crozier, A., Teissedre, P.L., The absorption, metabolism and excretion of flavan-3-ols and procyanidins following the ingestion of a grape seed extract by rats. Br. J. Nutr. 94 (2005), 170–181.
99. Vazquez Prieto, M.A., Bettaieb, A., Rodriguez Lanzi, C., Soto, V.C., Perdicaro, D.J., Galmarini, C.R., Haj, F.G., Miatello, R.M., Oteiza, P.I., Catechin and quercetin attenuate adipose inflammation in fructose-fed rats and 3T3-L1 adipocytes. Mol. Nutr. Food Res. 59 (2015), 622–633.
100. Verbeek, R., van Tol, E.A.F., van Noort, J.M., Oral flavonoids delay recovery from experimental autoimmune encephalomyelitis in SJL mice. Biochem. Pharmacol. 70 (2005), 220–228.
101. Verstraeten, S.V., Jaggers, G.K., Fraga, C.G., Oteiza, P.I., Procyanidins can interact with Caco-2 cell membrane lipid rafts: involvement of cholesterol. Biochim. Biophys. Acta 1828 (2013), 2646–2653.
102. Verstraeten, S.V., Keen, C.L., Schmitz, H.H., Fraga, C.G., Oteiza, P.I., Flavan-3-ols and procyanidins protect liposomes against lipid oxidation and disruption of the bilayer structure. Free Radic. Biol. Med. 34 (2003), 84–92.
103. Waldner, M.J., Neurath, M.F., The molecular therapy of colorectal cancer. Mol. Aspects Med. 31 (2010), 171–178.
104. Watson, J.L., Ansari, S., Cameron, H., Wang, A., Akhtar, M., McKay, D.M., Green tea polyphenol (-)-epigallocatechin gallate blocks epithelial barrier dysfunction provoked by IFN-gamma but not by IL-4. Am. J. Physiol. Gastrointest. Liver Physiol. 287 (2004), G954–G961.
105. Wells, J.M., Brummer, R.J., Derrien, M., MacDonald, T.T., Troost, F., Cani, P.D., Theodorou, V., Dekker, J., Meheust, A., de Vos, W.M., Mercenier, A., Nauta, A., Garcia-Rodenas, C.L., Homeostasis of the gut barrier and potential biomarkers. A m. J. Physiol. Gastrointest. Liver. Physiol 312 (2017), G171–G193.
106. Williamson, G., Clifford, M.N., Role of the small intestine, colon and microbiota in determining the metabolic fate of polyphenols. Biochem. Pharmacol. 139 (2017), 24–39.
107. Woo, H.D., Kim, J., Dietary flavonoid intake and risk of stomach and colorectal cancer. World J. Gastroenterol. 19 (2013), 1011–1019.
108. Xie, Y., Yang, W., Tang, F., Chen, X., Ren, L., Antibacterial activities of flavonoids: structure-activity relationship and mechanism. Curr. Med. Chem. 22 (2015), 132–149.
109. Xu, G., Dou, J., Zhang, L., Guo, Q., Zhou, C., Inhibitory effects of baicalein on the influenza virus in vivo is determined by baicalin in the serum. Biol. Pharm. Bull. 33 (2010), 238–243.
110. You, Q., Chen, F., Wang, X., Luo, P.G., Jiang, Y., Inhibitory effects of muscadine anthocyanins on alpha-glucosidase and pancreatic lipase activities. J. Agric. Food Chem. 59 (2011), 9506–9511.
111. Zamora-Ros, R., Barupal, D.K., Rothwell, J.A., Jenab, M., Fedirko, V., Romieu, I., Aleksandrova, K., Overvad, K., Kyro, C., Tjonneland, A., Affret, A., His, M., Boutron-Ruault, M.C., Katzke, V., Kuhn, T., Boeing, H., Trichopoulou, A., Naska, A., Kritikou, M., Saieva, C., Agnoli, C., Santucci de Magistris, M., Tumino, R., Fasanelli, F., Weiderpass, E., Skeie, G., Merino, S., Jakszyn, P., Sanchez, M.J., Dorronsoro, M., Navarro, C., Ardanaz, E., Sonestedt, E., Ericson, U., Maria Nilsson, L., Boden, S., Bueno-de-Mesquita, H.B., Peeters, P.H., Perez-Cornago, A., Wareham, N.J., Khaw, K.T., Freisling, H., Cross, A.J., Riboli, E., Scalbert, A., Dietary flavonoid intake and colorectal cancer risk in the European prospective investigation into cancer and nutrition (EPIC) cohort. Int. J. Cancer 140 (2017), 1836–1844.
112. Zhang, L., Wang, Y., Li, D., Ho, C.T., Li, J., Wan, X., The absorption, distribution, metabolism and excretion of procyanidins. Food Funct. 7 (2016), 1273–1281.